Wednesday, January 19, 2022

ASPIRE-BioNEST

Anti-diabetic drug proposed for Covid treatment

Hyderabad: Research by ReaGene Innovations Private Limited, a startup incubated at the ASPIRE-BioNEST, and INDRAS Private Limited suggests that an anti-diabetic drug Ertugliflozin, can...

UoH Startup and INDRAS research proposes drug for Covid-19 treatment

The first result offering a safe, ready-to-use and cost-effective solution for Covid-19 treatment, Ertugliflozin is an FDA approved drug for type-2 diabetes.

Hyderabad: ReaGene Biosciences bags emerging start-up award

A graduated startup company of ASPIRE-BioNEST incubator at UoH was identified as an emerging start-up company by an independent jury panel of ChemTech- Biopharma conference 2021

ASPIRE BioNEST of UoH selected as best emerging Bioincubator in the country

ASPIRE BioNEST, formed as a knowledge-based incubator, nurtures innovation and entrepreneurship in scaling technologies of Agriculture, Biotechnology, Healthcare, Pharmaceutical, and allied areas

UoH celebrates ASPIRE-BioNEST’s third foundation day

Growing rapidly from its establishment in 2018, ASPIRE BioNEST is currently hosting 25 start-ups in different areas of life sciences.

Latest News

- Advertisement -